文献速递流行病学与生物统计医学教育与科研方法

影响孕妇和哺乳期妇女参与临床试验的因素:一项混合方法系统综述

Factors influencing the participation of pregnant and lactating women in clinical trials: A mixed-methods systematic review.
PubMed 文献 · PLoS Med · 2024-05-30

该混合方法系统综述检索8个数据库至2024年2月14日,纳入来自27个国家的60篇文献,综合定性、定量与混合方法研究,分析影响孕妇和哺乳期妇女参与疫苗和治疗性临床试验的因素,归纳为5个主题并映射至理论域框架与COM-B模型,以制定行为改变策略。

要点

  • 女性参与意愿受感知风险与获益权衡、治疗乐观、干预可接受性、利他动机、亲密关系及对医学研究的信任影响。
  • 卫生工作者在感知临床均势、对新型治疗应用抱有希望且确信干预安全时支持孕妇参与试验。
  • 研究人员的招募受与卫生工作者的互惠关系、试验资源可及性、试验可见度、以女性为中心的沟通方式及情感倾向影响。

核心结论

  • 该综述揭示了影响孕妇和哺乳期妇女参与临床试验的多层面、多利益相关方的多样因素。
  • 通过将识别出的因素与行为改变框架相联系,作者开发了理论上 informed 的策略,可帮助优化孕妇和哺乳期妇女在此类试验中的参与、投入和信任。

研究设计与样本

  • 混合方法系统综述,检索8个数据库自建库至2024年2月14日,纳入定性、定量和混合方法研究。
  • 纳入60篇论文,来自27个国家。
  • 采用主题合成分析定性文献,使用GRADE-CERQual方法评估每个定性综述发现的置信度。
  • 将定量数据与主题合成发现进行比较以评估趋同或趋异领域。
  • 将综述发现映射至理论域框架(TDF)和能力-机会-动机行为模型(COM-B)以指导未来行为改变策略的开发。

主要发现

  • 将24项综述发现归入5个 overarching 主题:女性决策中感知参与风险与获益的相互作用;女性与医疗和研究系统之间的互动;性别规范和决策自主权;影响临床试验招募的因素;研究系统中的上游因素。
  • 女性的参与意愿受以下因素影响:感知的疾病健康风险与干预风险获益的权衡、治疗乐观、干预可接受性、对在试验中获得更高质量照护的期望、利他动机、亲密关系动态以及对医学和研究的权力与信任。
  • 卫生工作者在感知临床均势、对新型治疗应用抱有希望且确信干预安全时支持女性参与试验。
  • 对研究人员而言,与卫生工作者建立互惠关系、获得试验实施资源、确保试验对潜在参与者和卫生工作者可见、在与潜在参与者沟通时实施以女性为中心的方法以及对试验的情感倾向是感知影响招募的因素。
  • 对研究者和伦理委员会而言,风险评估和试验设计中的复杂性和主观性以及此类试验资金有限导致他们不愿主导和批准此类试验。

局限性

  • 所有纳入研究均关注影响顺性别孕妇参与临床试验的因素;未来研究应考虑其他有妊娠能力的人群,包括跨性别和非二元人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Poor representation of pregnant and lactating women and people in clinical trials has marginalised their health concerns and denied the maternal-fetal/infant dyad benefits of innovation in therapeutic research and development. This mixed-methods systematic review synthesised factors affecting the participation of pregnant and lactating women in clinical trials, across all levels of the research ecosystem. METHODS AND FINDINGS: We searched 8 databases from inception to 14 February 2024 to identify qualitative, quantitative, and mixed-methods studies that described factors affecting participation of pregnant and lactating women in vaccine and therapeutic clinical trials in any setting. We used thematic synthesis to analyse the qualitative literature and assessed confidence in each qualitative review finding using the GRADE-CERQual approach. We compared quantitative data against the thematic synthesis findings to assess areas of convergence or divergence. We mapped review findings to the Theoretical Domains Framework (TDF) and Capability, Opportunity, and Motivation Model of Behaviour (COM-B) to inform future development of behaviour change strategies. We included 60 papers from 27 countries. We grouped 24 review findings under 5 overarching themes: (a) interplay between perceived risks and benefits of participation in women's decision-making; (b) engagement between women and the medical and research ecosystems; (c) gender norms and decision-making autonomy; (d) factors affecting clinical trial recruitment; and (e) upstream factors in the research ecosystem. Women's willingness to participate in trials was affected by: perceived risk of the health condition weighed against an intervention's risks and benefits, therapeutic optimism, intervention acceptability, expectations of receiving higher quality care in a trial, altruistic motivations, intimate relationship dynamics, and power and trust in medicine and research. Health workers supported women's participation in trials when they perceived clinical equipoise, had hope for novel therapeutic applications, and were convinced an intervention was safe. For research staff, developing reciprocal relationships with health workers, having access to resources for trial implementation, ensuring the trial was visible to potential participants and health workers, implementing a woman-centred approach when communicating with potential participants, and emotional orientations towards the trial were factors perceived to affect recruitment. For study investigators and ethics committees, the complexities and subjectivities in risk assessments and trial design, and limited funding of such trials contributed to their reluctance in leading and approving such trials. All included studies focused on factors affecting participation of cisgender pregnant women in clinical trials; future research should consider other pregnancy-capable populations, including transgender and nonbinary people. CONCLUSIONS: This systematic review highlights diverse factors across multiple levels and stakeholders affecting the participation of pregnant and lactating women in clinical trials. By linking identified factors to frameworks of behaviour change, we have developed theoretically informed strategies that can help optimise pregnant and lactating women's engagement, participation, and trust in such trials.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Shankar M, Hazfiarini A, Zahroh RI, et al. Factors influencing the participation of pregnant and lactating women in clinical trials: A mixed-methods systematic review. PLoS Med. 2024. PMID: 38814991. doi:10.1371/journal.pmed.1004405

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。